We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESS icon
526
Essex Property Trust
ESS
$18.9B
$1.13M 0.02%
4,879
+1,087
+29% +$249K
WCN
527
Waste Connections
WCN
$42.8B
$1.12M 0.02%
+18,984
New +$1.06M
O icon
528
Realty Income
O
$61.2B
$1.11M 0.02%
19,318
+3,987
+26% +$231K
AZN icon
529
AstraZeneca
AZN
$263B
$1.11M 0.02%
17,840
– –
SHPG
530
DELISTED
Shire pic
SHPG
$1.11M 0.02%
6,373
– –
TAP icon
531
Molson Coors Class B
TAP
$7.68B
$1.1M 0.02%
11,490
+2,069
+22% +$202K
TCOM icon
532
Trip.com Group
TCOM
$27.5B
$1.08M 0.02%
22,000
-7,000
-24% -$321K
AVDL
533
DELISTED
Avadel Pharmaceuticals
AVDL
$1.07M 0.02%
+111,000
New +$1.11M
EFX icon
534
Equifax
EFX
$20.3B
$1.07M 0.02%
7,855
-977
-11% -$124K
ETR icon
535
Entergy
ETR
$54.1B
$1.07M 0.02%
28,214
-36,486
-56% -$1.34M
ADSK icon
536
Autodesk
ADSK
$44.3B
$1.07M 0.02%
12,328
+3,339
+37% +$279K
CIT
537
DELISTED
CIT Group Inc.
CIT
$1.06M 0.02%
24,799
+7,488
+43% +$317K
AGNC icon
538
AGNC Investment
AGNC
$12.3B
$1.04M 0.02%
52,378
+13,271
+34% +$256K
ULTA icon
539
Ulta Beauty
ULTA
$20.4B
$1.03M 0.02%
3,620
+866
+31% +$237K
TIF
540
DELISTED
Tiffany & Co.
TIF
$1.03M 0.02%
10,816
+1,621
+18% +$138K
MNST icon
541
Monster Beverage
MNST
$91.4B
$1.01M 0.02%
43,792
+9,898
+29% +$221K
MRO
542
DELISTED
Marathon Oil Corporation
MRO
$1M 0.02%
63,441
+13,863
+28% +$227K
MKL icon
543
Markel Group
MKL
$25B
$998K 0.02%
1,023
+120
+13% +$113K
OKE icon
544
Oneok
OKE
$58.7B
$997K 0.02%
17,982
+3,862
+27% +$212K
EMN icon
545
Eastman Chemical
EMN
$7.8B
$996K 0.02%
12,329
+3,270
+36% +$257K
LRMR icon
546
Larimar Therapeutics
LRMR
$416M
$993K 0.02%
17,750
+8,750
+97% +$434K
NOW icon
547
ServiceNow
NOW
$102B
$982K 0.02%
56,105
+13,120
+31% +$229K
FRT icon
548
Federal Realty Investment Trust
FRT
$10.9B
$978K 0.02%
7,329
+1,669
+29% +$231K
KLAC icon
549
KLA
KLAC
$275B
$967K 0.02%
101,680
-1,613,420
-94% -$14.2M
AKRX
550
DELISTED
Akorn Inc
AKRX
$963K 0.02%
+40,000
New +$871K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.